{"nct_id":"NCT01832727","title":"Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma","status":"TERMINATED","status_verified_date":"2020-06","start_date":"2013-07-02","start_date_type":"ACTUAL","primary_completion_date":"2019-06-25","primary_completion_date_type":"ACTUAL","completion_date":"2019-06-25","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["AMGN"]}